Drug-resistant tuberculosis is a form of tuberculosis that does not respond to the standard treatments due to resistance to one or more of the primary anti-TB drugs. This poses a significant public health challenge as it requires longer, more complex, and often less effective treatment regimens, increasing the risk of transmission and mortality.